http://orcid.org/0000-0001-7335-5169
Figures
Abstract
Background
Severe dengue infection often has unpredictable clinical progressions and outcomes. Obesity may play a role in the deterioration of dengue infection due to stronger body immune responses. Several studies found that obese dengue patients have a more severe presentation with a poorer prognosis. However, the association was inconclusive due to the variation in the results of earlier studies. Therefore, we conducted a systematic review and meta-analysis to explore the relationship between obesity and dengue severity.
Methods
We performed a systematic search of relevant studies on Ovid (MEDLINE), EMBASE, the Cochrane Library, Web of Science, Scopus and grey literature databases. At least two authors independently conducted the literature search, selecting eligible studies, and extracting data. Meta-analysis using random-effects model was conducted to compute the pooled odds ratio with 95% confidence intervals (CI).
Findings
We obtained a total of 13,333 articles from the searches. For the final analysis, we included a total of fifteen studies among pediatric patients. Three cohort studies, two case-control studies, and one cross-sectional study found an association between obesity and dengue severity. In contrast, six cohort studies and three case-control studies found no significant relationship between obesity and dengue severity. Our meta-analysis revealed that there was 38 percent higher odds (Odds Ratio = 1.38; 95% CI:1.10, 1.73) of developing severe dengue infection among obese children compared to non-obese children. We found no heterogeneity found between studies. The differences in obesity classification, study quality, and study design do not modify the association between obesity and dengue severity.
Author summary
Dengue fever, an Aedes mosquito-borne viral infection, is a self-limiting or asymptomatic viral infection. In its severe form, severe dengue, the symptoms include organ failure, life-threatening bleeding, and shock. Patients with obesity were found to be at higher risks of developing complications and severe dengue infection compared to non-obese patients. Our systematic review and meta-analysis critically compared the available shreds of evidence related to obesity and severe forms of dengue infection. A total of fifteen studies that include nine cohort studies, five case-control studies, and one cross-sectional study were reviewed to explore the association between obesity and dengue severity. The results indicated that obese patients have higher odds of developing severe dengue infection compared to non-obese patients. This review highlighted the importance of obesity in the progression of dengue infection. With increasing prevalence of obese individual as well as expanding areas that were at high risk for dengue infection, obesity may play a role in increasing the burden and mortality related to dengue infection. Further large-scale prospective studies in regions with high prevalence of dengue infections would provide additional information and some better discernment on the relevance of obesity in dengue infection.
Citation: Zulkipli MS, Dahlui M, Jamil N, Peramalah D, Wai HVC, Bulgiba A, et al. (2018) The association between obesity and dengue severity among pediatric patients: A systematic review and meta-analysis. PLoS Negl Trop Dis 12(2): e0006263. https://doi.org/10.1371/journal.pntd.0006263
Editor: Olaf Horstick, University of Heidelberg, GERMANY
Received: August 17, 2017; Accepted: January 23, 2018; Published: February 7, 2018
Copyright: © 2018 Zulkipli et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Data Availability: All relevant data are within the paper and its Supporting Information files.
Funding: This study was supported by the University of Malaya Research Grant ((UMRG Program) - HTM (Wellness)) [RP034B-15HTM] for SR and Postgraduate Research Grant (PPP), University of Malaya [PG163-2015B], University of Malaya for MSZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
Introduction
Dengue is an acute systemic viral infection caused by the dengue virus. Currently, there are four known dengue virus subtypes (DEN-1, DEN-2, DEN-3, DEN-4) with Aedes aegypti and Aedes albopictus as the principal vectors. The burdens of dengue infection were concentrated in the tropical and sub-tropical regions mainly in Asia, Caribbean, Africa, the Pacific, and the Americas.
Globally, an annual average of 9,221 fatal dengue cases was recorded between 1990 and 2013 [1]. In 2013 alone, dengue infection was responsible for 576,900 years-life-lost (YLL) and 1.14 million disability-adjusted-life-years (DALY) [1]. Only 25% of those infected with dengue were symptomatic [2]. The signs and symptoms of dengue infection include fever, nausea, vomiting, joint pain, muscular pain, retro-orbital pain, and spontaneous bleeding. The most important predictor of adverse dengue infection was the rapid decrease of platelets with increased hematocrit levels during the critical phase.
Currently, the most commonly used dengue classification is the WHO 2009 dengue classification. The WHO 2009 classification classified dengue into Dengue without Warning Signs (DWWS), Dengue with Warning Signs (DWS), and Severe Dengue (SD) [3]. Previously, dengue infection was classified using the WHO 1997 classification. The WHO 1997 classified dengue differently from WHO 2009 into Dengue Fever (DF), Dengue Hemorrhagic Fever (DHF), and Dengue Shock Syndrome (DSS). Studies have found that the WHO 2009 dengue classification into severity levels was 53 percent more sensitive in capturing severe dengue infection than the WHO 1997 dengue classification [4, 5]. Other dengue classifications include WHO 1986, 1999, and 2011.
Epidemiological studies have recognized several risk factors for severe dengue infection. Among the risk factors were the two extremes of age, under-nutrition, pregnancy, and secondary infections [6–10]. Furthermore, there were specific clinical signs and symptoms of acute dengue infection that links to severe dengue such as abdominal pain, vomiting, spontaneous bleeding, and diarrhea [11–13]. Nonetheless, other potential risk factors may have a role as novel predictors for dengue severity such as obesity, diabetes, chronic allergies, and hypertension [10, 14–18].
Overweight and obesity defined as abnormal or excessive fat accumulation that presents a risk to health. Depending on age, different methods were available to measure a body’s healthy weight according to age groups. We defined overweight and obesity using the WHO standards. In children and adolescents using age and sex cut-offs: (1) overweight defined as either body mass index (BMI) ≥ 85th percentile and < 95th percentile or weight-for-height percentage of > 110%; (2) obesity defined as either BMI ≥ 95th percentile or weight-for-height percentage of more than 120%. In adults, overweight defined as BMI ≥ 25 kg/m2 and < 30 kg/m2, and obesity was defined as ≥ 30 kg/m2 [19].
Obesity is a major Public Health problem. Globally, the prevalence of overweight and obesity rose by 27.5 percent for adults between 1980 and 2013. The number increased from 857 million in 1980 to 2.1 billion in 2013 [20]. In 2016, the WHO reported that the prevalence of overweight and obesity were at: (i) 21.9% and 4.7% in South-East Asia region; (ii) 49% and 20.8% in Eastern Mediterranean region; (iii) 31.7% and 6.4% in Western Pacific region; (iv) 31.1% and 10.6% in African region; and (v) 62.5% and 28.6% in Americas region, respectively [21, 22]. An estimate by Brady et al. on the prevalence of dengue showed that 3.9 billion people in 128 countries are at risk for dengue virus infection [23]. WHO also reported that dengue has spread to new areas such as France, Europe, China, and Japan [24].
Hypothetically, obesity may affect the severity of dengue infection through the inflammation pathways. The increased deposition of white adipose tissue (WAT) in the overweight and obese individual leads to increase production of inflammatory mediators that were known to increase the capillary permeability and causes plasma leakage [25–27].
In 2013, Huy NT et al. published a systematic review and meta-analysis of 198 studies up to September 2010 on factors associated with dengue shock syndrome. In the sub-analysis of eight primary studies, the author found that obesity was no association between DSS and overweight or obesity [28]. Recently, in 2016, Trang et al. published a systematic review and meta-analysis of thirteen studies up to August 2013 on the association between nutritional status and dengue infection [29]. The meta-analysis of eight primary studies on overweight and obesity found no significant association between overweight/obese and DSS. However, the author failed to show substantial consistency regarding the relationship between studies and concluded that the effects of nutritional status on dengue outcomes were controversial. Similarly, both systematic reviews by Huy NT et al. and Trang et al. focused only on the association between nutritional status and dengue infection with studies up to August 2013.
There were scarce and inconclusive shreds of evidence linking overweight and obesity with the severity of dengue infection [30, 31]. The number obese individuals susceptible to dengue will significantly increase with the increasing prevalence of obesity and increasing populations susceptible to dengue infection. With the hypothesized link between obesity and increasing plasma leakage, obese individuals may be at higher risk of developing severe dengue infection. Our review aims to summarize the current evidence on the association between obesity and severe dengue infection and to identify patients with high risk of severe infection. To our knowledge, this is the first systematic review and meta-analysis on the association between obesity and dengue severity.
Materials and methods
We conducted this systematic review and meta-analysis according to the recommendations of the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement [32]. We had registered the protocol for this study with the PROSPERO International prospective register of systematic reviews (No. CRD: 42016046944).
Literature searching and selection criteria
Review question and search strategy.
Using the P.I.C.O strategy (an acronym for population or problem, intervention or exposure of interest, comparison, and outcome) for framing review question [33], we framed the review question as: "do the severity of dengue infection associated with obesity?" Based on the review question, we developed a search strategy for each database using the search terms as described in Table 1. In total, we searched five databases, i.e., Ovid (MEDLINE), the Cochrane Library, EMBASE, Web of Science, and Scopus for relevant studies.
We searched four databases with a date of search from the inceptions until July 12, 2017. Due to administrative issues, we also managed to search EMBASE from their inception until September 21, 2016. Furthermore, we explored the keyword "dengue" on other remaining libraries including the New York Academy of Medicine Grey Literature Report (NYAM), African Index Medicus (AIM), System for Information on Grey Literature in Europe (SIGLE) and African Journals OnLine (AJOL). We also screened the references of relevant reviews manually to find related articles for our review [28, 29].
Inclusion and exclusion criteria
We included all interventional and observational studies that evaluated the association between obesity and dengue outcomes. We also added any studies that have information on dengue patients together with information on body compositions such as weight, height, body mass index (BMI) and waist circumference (WC). We excluded articles with the following characteristics: (i) letter, case report, review, or conference paper; (ii) animal study; and (iii) in vitro study without patients. MSZ and NAJ independently examined and screened the titles and abstracts for eligibility. There is no restriction with regards to age and publication language.
Screening
We imported the relevant articles retrieved from the searches to EndNote X7.7.1 software (Thomson Reuters, Philadelphia). Duplicates were removed primarily using the EndNote software and manually by identification of similar title, author, and the year before the screening process. MSZ also translated one Indonesian article into English during the screening process. Next, the remaining studies were carefully appraised from title and abstract to identify those that may be related to the review question. We based the identification process on the PRISMA flowchart [32]; i.e., identification, screening, eligibility, and study inclusion. We resolved any disagreements in selection by consensus between authors.
Data extraction
We acquired the full-text version of all eligible studies from its databases digitally. MSZ and NAJ reviewed all available full text before data extraction independently. We developed a Google form for data extraction that includes information on the first author, publication year, recruitment, study design, data collection process, allocation of patients (sequential or random), and study site. The form also included characteristics of the patient population, sample size, dengue criteria), index of obesity (BMI, BMI Z-score, BMI-for-age, weight, weight-for-age, height, waist circumference), measurement tools for body composition, and age distributions of the patients. Data were then extracted independently by MSZ and NAJ, and verified by SR and MD.
The outcome measured in this review was severe dengue infection compared to non-severe dengue infection. We defined severe dengue infection as a collective term that includes either DHF grade III, DHF grade IV, dengue with warning signs, DSS, or severe dengue. Non-severe dengue group includes either DF, DHF grade I, DHF grade II, or dengue without warning signs. The exposure was defined as obesity that includes overweight. The reference group of exposure defined as non-obese includes patients with normal weight and underweight.
Quality assessment
The quality of the included studies was appraised using the Newcastle-Ottawa Scale (NOS) [34]. The NOS evaluated study quality based on three quality parameters (selection, comparability, and outcome) divided across eight specific items. Each item on the scale was scored from one point to score up to two points. Currently, there was no specific cut-off score for stratification of study into good, poor, and moderate. Based on our literature search, we found that a cut-off score of seven or more was used to consider a study of good quality. A score between five and six was considered as moderate quality study and anything lesser than five was considered as a poor quality study [35]. Thus, we adopted the similar cut-off score and pair the score with traffic light color coding as described in S1 Table for assessment of study quality in this review.
Statistical analysis
We conducted the meta-analysis using Stata 14 (StataCorp, Texas) and considered p<0.05 as statistically significant. We used random-effects model for meta-analysis of the association between obesity and dengue severity. The random-effect compared to fixed-effect model is a more robust model by accounting for the variation between the actual effect estimates of included studies. Before pooling the odds ratio estimate, we calculated the individual odds ratio of developing severe dengue infection among obese patients compared to non-obese patients using the available information extracted from the included studies. We computed the pooled odds ratio estimate by weighting each estimate using the inverse variance method. Forest plot and I2 statistic were used to illustrate the combined estimate and evaluate heterogeneity, respectively.
In our sensitivity analyses, we used meta-regression to explore the effect of heterogeneity by obesity category (overweight/obesity and obesity), study quality (good, moderate, poor), and study design (cohort, case-control, cross-sectional). Publication bias was assessed using a funnel plot and Egger’s Test. We assumed missingness of any outcomes to be missing completely at random.
Results
Study selection process
We identified a total of 13,333 potential reports from five databases and references screening of three earlier relevant reviews [28, 29], with 3,411 duplicate reports. We included sixty-four reports for the full-text review. Furthermore, we excluded forty-nine reports that did not fulfill the inclusion and exclusion criteria. Finally, we included fifteen reports for systematic review and meta-analysis. The process of study selection was presented in the PRISMA 2009 Flow Diagram (Fig 1) [32].
Descriptive analysis
Designs, settings, and subjects.
The fifteen studies were from 2000 to 2016 [10, 31, 36–48]. Table 2 summarized all available information of the included studies presented in Table 2. Most studies were conducted in Asia (seven from Indonesia, five from Thailand, and one from Sri Lanka) [10, 31, 36–43, 45, 46, 48] while another two articles were from El Salvador and Paraguay [44, 47]. There were nine cohort studies [36–39, 42, 44, 45, 47, 48], five case-control studies [10, 31, 40, 41, 46], and one cross-sectional study [43]. All fifteen studies only included pediatric patients as subjects.
Study objectives of included studies
There was a broad range of objectives amongst the included studies. Three studies analyzed the association between nutritional status with dengue severity [10, 42, 44]. Five studies assessed the risk factors for dengue severity and dengue shock syndrome among children infected with dengue [31, 38, 40, 41, 47]. Remaining studies evaluated childhood obesity as a prognostic factor for dengue shock syndrome [45]; described the clinical disease patterns among children hospitalized for dengue [39]; determined the transfusion requirement among dengue infected patients [36]; analyzed the factor involved in thrombocytopenia and platelet aggregation among dengue hemorrhagic fever patients [37]; examined the association between blood zinc levels and its connection to the severity of dengue hemorrhagic fever clinically [43]; assessed the association between serum transaminase levels and the presence of dengue shock syndrome among children [46]; and determined the levels and correlation between interleukin-8 concentration on admission and dengue shock syndrome outcomes in children [48].
Sample size and inclusion criteria used in the included studies
The fifteen studies included a total of 7,133 dengue patients with age ranged between 0 and 18 years old. All studies had a clear description of the inclusion criteria. Eleven studies included laboratory-confirmed dengue cases, and the other four [36, 43, 46, 48] studies did not report on the method used for confirmation of dengue cases. The diagnosis was confirmed using either serological test (hemagglutination inhibition or ELISA), viral isolation, or polymerase chain reaction (PCR) test.
Exposures, tools of measurement, and measures of association
From all fifteen studies, ten studies used obesity [10, 31, 37, 39–42, 45, 47, 48], four studies used overweight [36, 38, 44, 46], and one study used over-nutrition [43] as the exposure. The measurement of obesity, overweight, and over-nutrition differ amongst studies. Six studies utilized weight-for-age [10, 31, 36, 38, 41, 42], three studies used BMI-for-age [39, 43–45], one study used weight-for-height [40], while five other studies did not mention the method used to measure the exposure [37, 46–48].
One in fifteen studies evaluated the possibility of obesity as a prognostic factor for dengue shock syndrome [45]. Two studies used nutritional status as their primary exposure for dengue severity [10, 44]. Seven studies analyzed the risk factors for dengue severity which include age, sex, nutritional status, as well as other clinical and laboratory risk factors [31, 38–42, 47]. In remaining five studies, the author presented obesity, overweight, or over-nutrition as ancillary results [36, 37, 43, 46, 48].
Primary outcome and dengue classification
All five case-control studies defined dengue shock syndrome as the primary outcome [10, 31, 40, 41, 46]. For cohort study, five studies considered dengue shock syndrome as their primary outcome [36, 38, 45, 47, 48]. The remaining four studies used dengue hemorrhagic fever [42, 44] and severe dengue infection (dengue hemorrhagic grade III and IV) [37, 39] as their primary outcomes. While in the cross-sectional study [43], the author described the proportion of over-nutrition among all grade of dengue fever (grade I—IV).
All fifteen studies adopted various World Health Organization classifications of dengue. One study used the WHO 1986 criteria [36]. Nine studies used the WHO 1997 criteria [10, 37, 38, 40–42, 44–46]. Two studies used the WHO 1999 criteria [39, 43]. One study used the WHO 1999a criteria [31]. One study used the WHO 2009 criteria [47], and one study used the WHO 2011 criteria [48].
Quality of studies
According to the assessment of study quality using the Newcastle-Ottawa Quality Assessment Scale, we classified nine studies as good quality studies [10, 31, 37–39, 42–44, 48] and six studies as moderate quality studies [36, 40, 41, 45–47]. Table 3 summarized the total score acquired for each quality domain. Based on the selection domain, six studies [36, 40, 41, 45–47] scored two out of four points, six studies [38, 44–48] scored three out of four points, and three studies [37, 39, 42] scored four over four quality score points. In the comparability domain, eleven studies [10, 31, 36, 38, 40–43, 45–47] scored one over two points, and four studies [37, 39, 44, 48] scored a full point of two over two. In the exposure domain, all fifteen studies scored three out of four quality score points. By study design, eight [37–39, 42, 44, 45, 47, 48] out of nine cohort studies were classified as good quality studies and one [36] as a moderate quality study. Furthermore, one [46] case-control study was classified as good quality study while four case-control [10, 31, 40, 41] studies were classified as moderate quality. The only cross-sectional study [43] in this review was classified as a moderate quality study.
Summary of the results of the studies
Cross-sectional study.
The only cross-sectional study in this review investigated the association between blood zinc levels and dengue severity. Primarily, the author found no association between zinc levels and clinical severity of DHF in children. However, based on the available descriptive analysis results, a higher average of body mass index (BMI) among those with DHF grade IV was found (BMI 18.8 ± 7.2).
Case-control studies.
Among five case-control studies, two studies suggested an association between obesity and dengue severity [31, 40]. Both studies found higher odds of dengue severity among those who were obese. Moreover, Junia et al. also found that overweight was among the risk factors for dengue shock syndrome together with age five to nine years old, prolonged vomiting, persistent abdominal pain, and massive bleeding [40].
In contrast, three remaining case-control studies found no significant association between obesity and dengue severity [10, 41, 46]. However, Kalayanarooj et al. found a higher percentage of the overweight and obese patient among their study participants. The author also found that obese patients have a more unusual presentation and complications compared to those in the normal and malnourish group. Furthermore, complication such as encephalopathy (1.3%, 0.5% and 1.2%), associated infections (4.8%, 2.7% and 3.1%), and fluid overloaded (6.5%, 3.2%, and 2.1%) were also found among obese patients.
Cohort studies.
Among all included cohort studies, five studies analyzed the potential risk factors for dengue severity [38, 42, 44, 45, 47] Three other studies did not measure the association between obesity and dengue severity as their primary objective [36, 37, 48].
Six studies found no significant association between obesity and dengue hemorrhagic fever as well as dengue shock syndrome [38, 39, 44, 45, 47, 48]. Widiyati et al. who evaluated the role of childhood obesity as a prognostic factor for dengue shock syndrome, concluded that obesity was not a significant risk factor for dengue shock syndrome (OR = 1.03; 95% CI:0.32,3.31; p = 0.07) [45]. Similarly, Malavige et al. concluded that patients with BMI-for-age above 90th centile did not seem to modify the risk of severe dengue infection [39]. Maron et al. also found no differences in the BMI-for-age Z-scores or weight-for-age between dengue fever, dengue hemorrhagic fever, and healthy control group [44]. In contrast, three cohort studies found a higher percentage of obese patients among the severe group when compared to non-severe group [36, 37, 42]. Chuansumrit et al. concluded that the occurrence of dengue hemorrhagic fever grade III or IV was more prominent in patients whose body weight exceeds the 50th percentile for age [36]. Similarly, Bongsebandhu et al. and Basuki et al. found a higher percentage of obese among dengue hemorrhagic fevers patients [37, 42].
Meta-analysis
We first pooled the odds ratio for all fifteen studies [10, 31, 36–48] evaluating the association between obesity and dengue severity. We found that dengue patients who were obese have 38 percent higher odds of developing a severe presentation of dengue infection compared to non-obese dengue patients (OR = 1.38; 95% CI:1.10,1.73; p = 0.01; I2 = 36.7%) (Fig 2). We found no significant heterogeneity between studies (p = 0.08). There was no statistical evidence of publication bias based on the funnel plot (Fig 3) and Egger’s Test (p = 0.06). In sensitivity analyses using meta-regression, there was no statistical evidence of heterogeneity in obesity classification (p = 0.72), study quality (p = 0.84), nor study design (p = 0.67).
As a secondary analysis, we compared obese group in thirteen studies [10, 31, 36–42, 44, 46–48] with different comparison groups that include: (i) normal weight and underweight; (ii) normal weight; and (iii) underweight. From the pooled analyses, we found that the odds of developing severe dengue infection among the obese group were lower and not statistically significant when compared with the underweight group (OR = 1.26; 95% CI:0.93,1.72; p = 0.14). A significant higher odds ratio was found when we compared obese to normal/underweight group (OR = 1.31; 95% CI:1.04,1.65; p = 0.02) and normal weight group (OR = 1.33; 95% CI:1.04,1.70; p = 0.03) (Fig 4).
Discussion
Our systematic review found a significant association between obesity and dengue severity among children. We found that there were 38 percent higher odds of developing severe dengue infection among obese dengue patients compared to non-obese patients. The results of this review support our hypothesis that obese patients have more severe dengue infection compared to non-obese patients. These findings may be useful in the identification of high-risk dengue patients. Based on our literature review, obese patients were found to be at high risk of developing complication and death due to their stronger immune response compared to malnourished patients [10]. Hypothetically, obesity may affect the severity of dengue through inflammation pathways. The increased deposition of white adipose tissue (WAT) in obese individuals leads to an increased production of Interleukin-six (IL-6), Interleukin-eight (IL-8), and Tumor Necrosis Factor-Alpha (TNF-α) [25–27]. IL-6, IL-8, and TNF-a were essential mediators of the inflammation pathway that increases capillary permeability.
An increased capillary permeability in obese dengue patients may progressively underlie the process of severe plasma leakage. Thus, with increasing prevalence of obesity in regions with high-risk of dengue infection and the hypothesized link between obesity and dengue severity, an early detection of obese dengue patients was required for closer monitoring and early treatment.
Our systematic review found that the included studies defined and measured obesity differently using a different index of measurements such as BMI-for-age, weight-for-age, and weight-for-height. We also found that there were differences in study quality and study design. However, based on our statistical analysis, no heterogeneity found between obesity classification, study quality, and study design. Thus, we concluded that the differences in obesity classification, study quality, and study design do not modify the association between obesity and severity of dengue infection.
There were also differences in types of dengue classification used between studies. Since 2009, multiple revisions on the dengue classification have been done by the World Health Organization (WHO) to improve dengue patient management. Currently, the latest classification of dengue categorizes dengue patient into dengue fever, dengue with warning signs, dengue without warning signs and severe dengue. Most studies in this review were using the WHO 1997 dengue classification. Among all, only two studies [47, 48] used the latest WHO classification (2009, 2011) to classify their dengue cases. We did not reclassify cases using the WHO 2009 classification due to the unavailability of the raw data and also to the fact that the WHO 2009 classification classified dengue severity differently based on the presence of warning signs and severe dengue. Thus, with currently available information, it was difficult for us to reclassify all patients as it may lead to selection bias towards the more severe group.
Apart from that, all studies included in this review focused only on subjects age between 0 and 18 years old. The unavailability of adult patients limits the applicability of our findings to the general population. With regards to study settings, most of the included studies focus only on hospitalized patients. The hospital settings will encounter more severe dengue cases than primary health care settings. By restricting the study subject to hospitalized patients might introduce bias. It also limits the analysis to a more limited severe dengue group and left out the non-hospitalized group which might be less severe. Therefore, studies related to risk factors or prognostic factors should also include primary healthcare facilities.
Based on our literature review, there were higher risks of developing DHF and DSS among individuals with co-morbidities such as diabetes and hypertension[49]. We believed the association between these co-morbidities might be an effect modifier that increases the risk of severe dengue infection but limited only to adult patients. The pathophysiology underlying the effects was not clearly understood as there were not many earlier studies were available. We also found that significantly higher rates of general and central obesity were reported among men and women with higher socioeconomic status in South Asian nations [50, 51]. In most of the developing countries of South Asia region, the magnitude of household out-of-pocket expenditures on health was at times as high as 80 percent of the total amount spent on health care per annum [52].
We believed that there was a better health-seeking behavior among obese individuals compared to a non-obese individual due to their accessibility for better health care options. Thus, more obese patients were recorded from hospital compared to non-obese patients. We could not ascertain the association between the presence of co-morbidities among obese patients as well as effects of the socioeconomic status of obese patients and severity of dengue infection due to scarce information available.
This review has its limitations. We acknowledged the misclassification of obesity due to our inclusion of overweight and over-nutrition. However, we expect the bias to be towards the null as both overweight and over-nutrition refer to similar measures of body composition that is above normal weight. Furthermore, we accepted that the exclusion of fifteen patients from the study by Chuansumrit et al. was due to unavailability of body measurement data [36]. Another seventy-four [44] and seven-hundred-thirty-four controls [10] were also not included because our study does not include the non-dengue patients. Moreover, we also acknowledged that no study with adult participants was included in this review. The unavailability of studies with adult participants might be because previously the distributions of dengue infection were more prevalent among children and less severe among adults.
Also, all fifteen included studies were heterogeneous regarding classification, exposure, and outcomes, thus making it more challenging to compare and infer the results. However, these problems were adequately addressed by including all studies that associated with the research question, and not excluding it for lack of quality.
Conclusion
In conclusion, our systematic review and meta-analysis identified a significant association between obesity and dengue severity. The results presented highlight the importance of obesity in dengue infection. It also improves our understanding of the effect of obesity in influencing the severity of dengue infection among children. Further large-scale prospective cohort studies on the effects of obesity on dengue severity among adults and children especially in regions with high prevalence of dengue could provide additional information as well as better understanding on the relevance of obesity in dengue infection.
Supporting information
S1 Table. Cut-off score points for study quality assessment.
https://doi.org/10.1371/journal.pntd.0006263.s003
(PDF)
S3 Table. Calculated odds ratio of individual study.
https://doi.org/10.1371/journal.pntd.0006263.s005
(PDF)
References
- 1. Stanaway JD, Shepard DS, Undurraga EA, Halasa YA, Coffeng LE, Brady OJ, et al. The global burden of dengue: an analysis from the Global Burden of Disease Study 2013. Lancet Infect Dis. 2016;16(6):712–23. Epub 2016/02/15. pmid:26874619; PubMed Central PMCID: PMCPMC5012511.
- 2. Bhatt S, Gething PW, Brady OJ, Messina JP, Farlow AW, Moyes CL, et al. The global distribution and burden of dengue. Nature. 2013;496(7446):504–7. Epub 2013/04/09. pmid:23563266; PubMed Central PMCID: PMCPMC3651993.
- 3. World Health Organization. Handbook for Clinical Management of Dengue. 2012.
- 4. Basuki PS, Budiyanto , Puspitasari D, Husada D, Darmowandowo W, Ismoedijanto , et al. Application of revised dengue classification criteria as a severity marker of dengue viral infection in Indonesia. Southeast Asian J Trop Med Public Health. 2010;41(5):1088–94. Epub 2010/11/16. pmid:21073029.
- 5. Narvaez F, Gutierrez G, Perez MA, Elizondo D, Nunez A, Balmaseda A, et al. Evaluation of the traditional and revised WHO classifications of Dengue disease severity. PLoS Negl Trop Dis. 2011;5(11):e1397. Epub 2011/11/17. pmid:22087348; PubMed Central PMCID: PMCPMC3210746.
- 6. Guzman MG, Alvarez M, Halstead SB. Secondary infection as a risk factor for dengue hemorrhagic fever/dengue shock syndrome: an historical perspective and role of antibody-dependent enhancement of infection. Arch Virol. 2013;158(7):1445–59. Epub 2013/03/09. pmid:23471635.
- 7. Lee MS, Hwang KP, Chen TC, Lu PL, Chen TP. Clinical characteristics of dengue and dengue hemorrhagic fever in a medical center of southern Taiwan during the 2002 epidemic. J Microbiol Immunol Infect. 2006;39(2):121–9. Epub 2006/04/11. pmid:16604244.
- 8. Hammond SN, Balmaseda A, Perez L, Tellez Y, Saborio SI, Mercado JC, et al. Differences in dengue severity in infants, children, and adults in a 3-year hospital-based study in Nicaragua. Am J Trop Med Hyg. 2005;73(6):1063–70. Epub 2005/12/16. pmid:16354813.
- 9. Machado CR, Machado ES, Rohloff RD, Azevedo M, Campos DP, de Oliveira RB, et al. Is pregnancy associated with severe dengue? A review of data from the Rio de Janeiro surveillance information system. PLoS Negl Trop Dis. 2013;7(5):e2217. Epub 2013/05/16. pmid:23675548; PubMed Central PMCID: PMCPMC3649957.
- 10. Kalayanarooj S, Nimmannitya S. Is dengue severity related to nutritional status? Southeast Asian J Trop Med Public Health. 2005;36(2):378–84. Epub 2005/05/27. pmid:15916044.
- 11. Phuong CX, Nhan NT, Kneen R, Thuy PT, van Thien C, Nga NT, et al. Clinical diagnosis and assessment of severity of confirmed dengue infections in Vietnamese children: is the world health organization classification system helpful? Am J Trop Med Hyg. 2004;70(2):172–9. Epub 2004/03/03. pmid:14993629.
- 12. Cao XT, Ngo TN, Wills B, Kneen R, Nguyen TT, Ta TT, et al. Evaluation of the World Health Organization standard tourniquet test and a modified tourniquet test in the diagnosis of dengue infection in Viet Nam. Trop Med Int Health. 2002;7(2):125–32. Epub 2002/02/14. pmid:11841702.
- 13. Lee VJ, Lye DC, Sun Y, Leo YS. Decision tree algorithm in deciding hospitalization for adult patients with dengue haemorrhagic fever in Singapore. Trop Med Int Health. 2009;14(9):1154–9. Epub 2009/07/25. pmid:19624479.
- 14. Maria Aparecida A. Figueiredo , Rodviputal , Barrets ML. Allergies and diabetes as risk factors for DHF. Results of a case control study. Tropical Disease. 2010;(6):16–9.
- 15. Teixeira MG, Paixao ES, Costa Mda C, Cunha RV, Pamplona L, Dias JP, et al. Arterial hypertension and skin allergy are risk factors for progression from dengue to dengue hemorrhagic fever: a case control study. PLoS Negl Trop Dis. 2015;9(5):e0003812. Epub 2015/05/23. pmid:25996882; PubMed Central PMCID: PMCPMC4440722.
- 16. Chen CY, Lee MY, Lin KD, Hsu WH, Lee YJ, Hsiao PJ, et al. Diabetes mellitus increases severity of thrombocytopenia in dengue-infected patients. Int J Mol Sci. 2015;16(2):3820–30. Epub 2015/02/13. pmid:25674854; PubMed Central PMCID: PMCPMC4346928.
- 17. Pang J, Salim A, Lee VJ, Hibberd ML, Chia KS, Leo YS, et al. Diabetes with hypertension as risk factors for adult dengue hemorrhagic fever in a predominantly dengue serotype 2 epidemic: a case control study. PLoS Negl Trop Dis. 2012;6(5):e1641. Epub 2012/05/09. pmid:22563519; PubMed Central PMCID: PMCPMC3341340.
- 18. Htun NS, Odermatt P, Eze IC, Boillat-Blanco N, D'Acremont V, Probst-Hensch N. Is diabetes a risk factor for a severe clinical presentation of dengue?—review and meta-analysis. PLoS Negl Trop Dis. 2015;9(4):e0003741. Epub 2015/04/25. pmid:25909658; PubMed Central PMCID: PMCPMC4409149.
- 19. World Health Organization. Global Strategy on Diet, Physical Activity and Health 2017. Available from: http://www.who.int/dietphysicalactivity/childhood_what/en/.
- 20. Ng M, Fleming T, Robinson M, Thomson B, Graetz N, Margono C, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2014;384(9945):766–81. Epub 2014/06/02. pmid:24880830; PubMed Central PMCID: PMCPMC4624264.
- 21. World Health Organization. Global Health Observatory data repository: Prevalence of overweight among adults, BMI ≥ 30, age-standardized estimates by WHO region. 2017. Available from: http://apps.who.int/gho/data/view.main.REGION2480A?lang=en.
- 22. World Health Organization. Global Health Observatory data repository: Prevalence of overweight among adults, BMI ≥ 25, age-standardized estimates by WHO region. 2017. Available from: http://apps.who.int/gho/data/view.main.GLOBAL2461A?lang=en.
- 23. Brady OJ, Gething PW, Bhatt S, Messina JP, Brownstein JS, Hoen AG, et al. Refining the Global Spatial Limits of Dengue Virus Transmission by Evidence-Based Consensus. PLoS Neglected Tropical Diseases. 2012;6(8).
- 24. World Health Organization. Dengue and Severe Dengue 2017. Available from: http://www.who.int/mediacentre/factsheets/fs117/en/.
- 25. Bosch I, Xhaja K, Estevez L, Raines G, Melichar H, Warke RV, et al. Increased production of interleukin-8 in primary human monocytes and in human epithelial and endothelial cell lines after dengue virus challenge. J Virol. 2002;76(11):5588–97. Epub 2002/05/07. pmid:11991987; PubMed Central PMCID: PMCPMC137016.
- 26. Juffrie M, Meer GM, Hack CE, Haasnoot K, Sutaryo , Veerman AJ, et al. Inflammatory mediators in dengue virus infection in children: interleukin-6 and its relation to C-reactive protein and secretory phospholipase A2. Am J Trop Med Hyg. 2001;65(1):70–5. Epub 2001/08/16. pmid:11504411.
- 27. Calabro P, Chang DW, Willerson JT, Yeh ET. Release of C-reactive protein in response to inflammatory cytokines by human adipocytes: linking obesity to vascular inflammation. J Am Coll Cardiol. 2005;46(6):1112–3. Epub 2005/09/20. pmid:16168299.
- 28. Huy NT, Van Giang T, Thuy DH, Kikuchi M, Hien TT, Zamora J, et al. Factors associated with dengue shock syndrome: a systematic review and meta-analysis. PLoS Negl Trop Dis. 2013;7(9):e2412. pmid:24086778; PubMed Central PMCID: PMCPMC3784477.
- 29. Trang NTH, Long NP, Hue TTM, Hung LP, Trung TD, Dinh DN, et al. Association between nutritional status and dengue infection: A systematic review and meta-analysis. BMC Infectious Diseases. 2016;16(1).
- 30. Mahdalena Tri Widiyati Maria, Safitri Laksanawati Ida, Paryanto Prawirohartono Endy. Obesity as a risk factor for dengue shock syndrome in children. Paediatrica Indonesiana. 2013;53(4):187–92. http://dx.doi.org/10.14238/pi53.4.2013.187-92.
- 31. Pichainarong N, Mongkalangoon N, Kalayanarooj S, Chaveepojnkamjorn W. Relationship between body size and severity of dengue hemorrhagic fever among children aged 0–14 years. Southeast Asian J Trop Med Public Health. 2006;37(2):283–8. Epub 2006/11/28. pmid:17124987
- 32. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol. 2009;62(10):e1–34. pmid:19631507.
- 33.
O’Connor D GS, H JPT. Cochrane Handbook of Systematic Reviews of Intervention. Version 5.1.0 (updated March 2011): The Cochrane Collaboration; 2011.
- 34. Wells BS GA, O'Connell D, Peterson J, Welch V, Losos M, P. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses 2014. Available from: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp.
- 35. McPheeters ML, Kripalani S, Peterson NB, Idowu RT, Jerome RN, Potter SA, et al. Closing the quality gap: revisiting the state of the science (vol. 3: quality improvement interventions to address health disparities). Evid Rep Technol Assess (Full Rep). 2012;(208.3):1–475. Epub 2012/08/01. pmid:24422952; PubMed Central PMCID: PMCPMC4781280.
- 36. Chuansumrit A, Phimolthares V, Tardtong P, Tapaneya-Olarn C, Tapaneya-Olarn W, Kowsathit P, et al. Transfusion requirements in patients with dengue hemorrhagic fever. Southeast Asian J Trop Med Public Health. 2000;31(1):10–4. pmid:11023057.
- 37. Basuki PS. A Glance at the Von Willebrand Factor in Dengue Virus Infection. Southeast Asian Journal of Tropical Medicine and Public Health. 2003;34(3):559–63. pmid:15115128
- 38. Kan EF, Rampengan TH. Factors associated with shock in children with dengue hemorrhagic fever. Paediatrica Indonesiana. 2004;44(9–10):-165. Epub 2004-10-30.
- 39. Malavige GN, Ranatunga PK, Velathanthiri VG, Fernando S, Karunatilaka DH, Aaskov J, et al. Patterns of disease in Sri Lankan dengue patients. Arch Dis Child. 2006;91(5):396–400. pmid:16449254; PubMed Central PMCID: PMCPMC2082720.
- 40. Junia J, Garna H, Setiabudi D. Clinical risk factors for dengue shock syndrome in children. Paediatrica Indonesiana. 2007;47(1):7–11. Epub 2007-02-28.
- 41. Tantracheewathorn T, Tantracheewathorn S. Risk factors of dengue shock syndrome in children. J Med Assoc Thai. 2007;90(2):272–7. pmid:17375631.
- 42. Bongsebandhu-Phubhakdi C, Hemungkorn M, Thisyakorn U, Thisyakorn C. Risk factors influencing severity in pediatric Dengue infection. Asian Biomedicine. 2008;2(5):409–13.
- 43. Widagdo . Blood zinc levels and clinical severity of dengue hemorrhagic fever in children. Southeast Asian J Trop Med Public Health. 2008;39(4):610–6. pmid:19058597.
- 44. Marón GM, Clará AW, Diddle JW, Pleités EB, Miller L, MacDonald G, et al. Association between nutritional status and severity of dengue infection in children in el salvador. American Journal of Tropical Medicine and Hygiene. 2010;82(2):324–9. pmid:20134012
- 45. Widiyati MMT, Laksanawati IS, Prawirohartono EP. Obesity as a risk factor for dengue shock syndrome in children. Paediatrica Indonesiana. 2013;53(4):187–92. Epub 2013-08-31.
- 46. Putra Y, Arhana BNP, Safitri I, Widiana R. Serum transaminase levels and dengue shock syndrome in children. Paediatrica Indonesiana. 2014;54(3):181–5. Epub 2014-06-30.
- 47. Lovera D, de Cuellar CM, Araya S, Amarilla S, Gonzalez N, Aguiar C, et al. Clinical Characteristics and Risk Factors of Dengue Shock Syndrome in Children. Pediatr Infect Dis J. 2016. pmid:27455442.
- 48. Tatura SNN, Daud D, Yusuf I, Wahyuni S, Bernadus JB. Association between interleukin-8 and severity of dengue shock syndrome in children. Paediatrica Indonesiana. 2016;56(2):79–83. Epub 2016-07-19.
- 49. Mahmood Shahid, Hafeez Saadia, Nabeel Hiba, Zahra Urooj, Nazeer Hammad. Does Comorbidity Increase the Risk of Dengue Hemorrhagic Fever and Dengue Shock Syndrome? ISRN Tropical Medicine. 2013;2013:5.
- 50. Siddiquee T, Bhowmik B, Da Vale Moreira NC, Mujumder A, Mahtab H, Khan AKA, et al.—Prevalence of obesity in a rural Asian Indian (Bangladeshi) population and its determinants. 2015;- 15(- 1).
- 51. Jayawardena R, Byrne NM, Soares MJ, Katulanda P, Hills AP.—Prevalence, Trends and Associated Socio-Economic Factors of Obesity in South Asia. 2013;- 6(- 5):- 414.
- 52. Ha NT, Berman P, Larsen U. Household utilization and expenditure on private and public health services in Vietnam. Health Policy Plan. 2002;17(1):61–70. Epub 2002/02/28. pmid:11861587.